glp-1 agonists medications List of Receptor for Diabetes & Weight Loss The Impact of GLP-1 Receptor
Description
Instead, the SES containing 100 nM Ca 2+ failed to support the action of JWU-A021 to promote Ca 2+ influx
Clin Ther (2017) 39:134759
95% CI, 0.511.08)
[3] The risk of cardiovascular events was non-significantly reduced to 0.76 (95% confidence interval [CI] 0.46-1.28) and the risk of all-cause mortality was non-significantly reduced to 0.78 (95% CI 0.40-1.51)
Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial
